Key points are not available for this paper at this time.
The bioengineering of phages to display ligands leads to specific targeting, reduced toxicity, enhanced cellular uptake of an incorporated drug/gene and, ultimately, increased therapeutic efficacy.
Emencheta et al. (Mon,) studied this question.